Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Edible Vaccine Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The edible vaccine market has shown significant expansion in recent times. It is anticipated to increase from $9.51 billion in 2025 to $10.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this historical growth include advancements in genetic engineering techniques, pioneering research in transgenic plants for vaccines, the broadening of public health immunization programs, a rise in funding for alternative vaccine platforms, and initial clinical validation studies.
The edible vaccine market is projected for significant expansion over the coming years. This market is anticipated to reach $14.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. Factors driving this growth during the forecast period include the increasing demand for needle-free vaccination options, greater investments in edible vaccine clinical trials, the expansion of livestock immunization initiatives, a heightened emphasis on global vaccine accessibility, and progress in regulatory approval processes. Key trends expected within this period involve innovations in plant-based vaccine expression systems, an increasing emphasis on oral vaccine delivery methods, the spread of affordable vaccine production models, intensified research into heat-stable vaccines, and increasing partnerships between the biotechnology and agricultural industries.
Download A Free Sample Report For Comprehensive Market Insights:
Edible Vaccine Market Expansion Supported By Key Demand Factors
The expanding occurrence of infectious diseases is anticipated to fuel expansion in the edible vaccine market going forward. Infectious diseases are ailments caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites that enter the body and multiply. The heightened prevalence of infectious diseases is primarily due to factors such as global interconnectedness, climate shifts, urban development, and antimicrobial resistance, which facilitate the emergence and transmission of new pathogens. Edible vaccines are utilized for infectious diseases to activate immune responses through the consumption of genetically altered foods that produce antigens, providing an economical and injection-free immunization method. For instance, in March 2024, data from the Centers for Disease Control and Prevention (CDC), a US public health agency, indicated that the count of tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, representing an increment of 1,295 cases. Furthermore, the incidence rate per 100,000 individuals rose from 2.5 in 2022 to 2.9 in 2023. Consequently, the expanding prevalence of infectious diseases is propelling the growth of the edible vaccine market.
Edible Vaccine Market Driver: Rising Research And Development Funding Driving The Market Growth Due To Increasing Government Investment In Biotechnology Innovation
Edible Vaccine Market Segment Analysis And Revenue Opportunities
The edible vaccine market covered in this report is segmented –
1) By Vaccine Type: Subunit Vaccines, Virus-Like Particle VLP Vaccines, Plant-Expressed Antigen Vaccines, Recombinant Protein Vaccines, Other Edible Vaccine Types
2) By Source: Fruits, Vegetables, Cereal Grains, Legumes, Other Edible Plants
3) By Route of Administration: Oral Fresh Plant Consumption, Oral Processed Edible Form Feed, Sublingual And Buccal Edible Extract-Based
4) By Distribution Model: Public Health And Immunization Programs, Veterinary And Animal Health Programs, Direct Farm-Level Administration, Research And Academic Institutions
5) By Application: Human Immunization, Veterinary Vaccines, Livestock, Poultry, Aquaculture Vaccines, Other Applications
6) By End User: Adults, Pediatrics, Animals
Subsegments:
1) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines, Conjugated Subunit Vaccines
2) By Virus-Like Particle (VLP) Vaccines: Plant-Derived VLP Vaccines, Chimeric VLP Vaccines, Multi-Antigen VLP Vaccines
3) By Plant-Expressed Antigen Vaccines: Fruit-Based Edible Vaccines, Vegetable-Based Edible Vaccines, Grain-Based Edible Vaccines, Legume-Based Edible Vaccines
4) By Recombinant Protein Vaccines: Recombinant Bacterial Antigen Vaccines, Recombinant Viral Antigen Vaccines, Recombinant Parasitic Antigen Vaccines
5) By Other Edible Vaccine Types: Oral Mucosal Immunity-Targeted Vaccines, Multi-Epitope Edible Vaccines, Combination Edible Vaccines
Edible Vaccine Market Innovation Trends: Which Developments Are Transforming The Industry?
Major companies in the edible vaccine market are concentrating on creating advanced solutions, including the oral cholera vaccine (OCV), to address the global cholera challenge. The oral cholera vaccine (OCV) is a type of vaccine administered orally to prevent cholera, a serious diarrheal disease originating from the bacterium *Vibrio cholerae*. For instance, in August 2024, Bharat Biotech International Limited, an India-based biotechnology firm, unveiled Hillchol, an oral cholera vaccine (OCV) featuring numerous significant characteristics. This live-attenuated vaccine elicits both systemic and mucosal immune responses, safeguarding against cholera. Hillchol is distinguished by its effortless administration and lack of need for cold storage, making it practical for application in settings with limited resources. Additionally, it delivers lasting immunity with just one dose.
Edible Vaccine Market Leading Players Shaping Industry Direction
Major companies operating in the edible vaccine market are Medicago Inc., Vaxart Inc., Vaxiion Therapeutics Inc., Mymetics Corporation, Profectus BioSciences Inc., GreenLight Biosciences Inc., Akston Biosciences Corporation, Icon Genetics GmbH, iBio Inc., Kentucky BioProcessing Inc., Fraunhofer USA Center for Molecular Biotechnology, Nomad Bioscience GmbH, Baiya Phytopharm Company Limited, Dow AgroSciences LLC, GenCure Biomanufacturing, Transgene SA, PlantForm Corporation, BioBetter Ltd., Moolec Science SA, Agrenvec SL
Access The Complete Edible Vaccine Market Report:
Edible Vaccine Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the edible vaccine market in 2025. The regions covered in the edible vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.